Abstract:OBJECTIVE: This study aimed to investigate the expression of miR-31 in rectal cancer patients and its effect on the proliferation and invasion ability of human rectal cancer cells SW837. PATIENTS AND METHODS: 55 rectal cancer cancerous tissue specimens and 55 corresponding adjacent tissue (tissue adjacent to carcinoma) specimens were collected from rectal cancer patients treated in The First Hospital of Jilin University from March 2014 to March 2015. Real Time-quantitative Polymerase Chain Reaction was used for detecting the expression level of miR-31 in cancerous tissue and corresponding adjacent tissues. Differences in the expression of miR-31 were compared between the two groups. Different miR-31 expression vectors were established and rectal cancer cells SW837 were transfected. MTT was used for detecting the proliferation ability of the cells in the miR-31-mimics group, miR-31-inhibitor group and miR-control group. RESULTS: The expression level of miR-31 was significantly higher in rectal cancer tissues than that in the adjacent tissues (p<0.05). The expression of miR-31 was higher in the miR-31-mimics group (23.6 +/- 4.6) than that in the miR-control group (1.63 +/- 0.65), while the expression of miR-31 was lower in the miR-31-inhibitor group (0.65 +/- 0.23) than that in the miR-control group. The proliferation ability of cells at the 6th, 12th, 24th, 48th, and 72nd hours was higher in the miR-31-mimics group than in the miR-31-inhibitor group, while that of cells was significantly lower in the miR-31-inhibitor group than in the miR-control group, with statistically significant differences (p<0.05). The number of invasive membrane cells (cell membrane number) counted under a microscope was (84.2 +/- 10.6) cells in the miR-31-mimics group, (12.3 +/- 4.1) cells in the miR-31-inhibitor group, and (45.2 +/- 10.6) cells in the miR-control group. The invasion ability in vitro of SW837 cells significantly increased after the overexpression of miR-31 (p<0.05). CONCLUSIONS: miR-31 is increasingly expressed in rectal cancer. Low expression of miR31 can inhibit the proliferation and invasion ability of the cells. MiR-31 is expected to become a current biotherapeutic target.

Mir-31 Promotes Proliferation of Colon Cancer Cells by Targeting E2F2.

Mir-155 Regulates the Proliferation and Cell Cycle of Colorectal Carcinoma Cells by Targeting E2f2

miR-31 Promotes the Proliferation of Colorectal Cancer Cells Through Activating NF-κB Signal Pathway

Downregulated Mir-31 Level Associates With Poor Prognosis Of Gastric Cancer And Its Restoration Suppresses Tumor Cell Malignant Phenotypes By Inhibiting E2f2

Mir-592 Inhibited Cell Proliferation Of Human Colorectal Cancer Cells By Suppressing Of Ccnd3 Expression

Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

Mir-191 Promotes Tumorigenesis of Human Colorectal Cancer Through Targeting C/EBPβ.

Functions and mechanisms of microRNA-31 in human cancers

Mir-30d suppresses cell proliferation of colon cancer cells by inhibiting cell autophagy and promoting cell apoptosis

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)

Mir-449B Inhibits the Proliferation of SW1116 Colon Cancer Stem Cells Through Downregulation of CCND1 and E2F3 Expression

Elevated Microrna-31 Expression Regulates Colorectal Cancer Progression By Repressing Its Target Gene Satb2

Mir-30A Suppresses Breast Cancer Cell Proliferation and Migration by Targeting Eya2.

Expression of miR-301a in colorectal cancer and its influence on invasion and migration of colon cancer cells

MicroRNA-30d-5p Inhibits Tumour Cell Proliferation and Motility by Directly Targeting CCNE2 in Non-Small Cell Lung Cancer.

Mirna-331-3p Directly Targets E2F1 and Induces Growth Arrest in Human Gastric Cancer.

Expression of Mir-31 in Rectal Cancer Patients and Its Effect on Proliferation Ability of Rectal Cancer Cells SW837.

MicroRNA-335 Targets the MEK/ERK Pathway to Regulate the Proliferation and Metastasis of Colon Cancer

Mir-32 Inhibits Proliferation, Epithelial-Mesenchymal Transition, and Metastasis by Targeting Twist1 in Non-Small-Cell Lung Cancer Cells

microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway